Sluggish salty snack sales have prompted questions about whether Ozempic and obesity treatments like Wegovy and Zepbound ae to blame. GLP-1 drugs have...
Even as the major averages have recently hit fresh records, there are plenty of catalysts that could shake things up, including geopolitical tensions...
Beverage analysts don't see a threat to diet soda makers from the World Health Organization's recent warning on artificial sweetener aspartame. The United...